Urothelial Cancer Group / Japan Clinical Oncology Group / Wassenaar AE / CUETO Group / Nepple KG / EORTC Genito-Urinary Tract Cancer Group / Medline / Aprikian AG / /
Event
FDA Phase / /
Facility
Rink M / Club Urológico Español De Tratamiento Oncológico / /
IndustryTerm
therapy for bladder cancer / search terms / treatment of superficial bladder cancer / Treatment of Invasive Bladder Cancer / search term / search term bladder cancer / therapy for high-grade pT1 bladder cancer / search strategy / cancer treatment / treatment of recurrent disease / imaging / treatment of nonmuscle invasive bladder cancer / therapies for intermediate-risk superficial bladder cancer / treatment for Ta BCG failure / therapy for patients with nonmuscle invasive bladder cancer / literature search / upper tract imaging / /
MedicalCondition
updated noninvasive bladder cancer / urothelial carcinoma / DF / bladder cancer AND / JE / residual disease / male cancers / invasive disease / transitional cell carcinoma / metastasis / Bladder cancer / carcinoma / T1 bladder cancer / nonmuscle invasive bladder cancer / multifocal tumours / carcinoma in situ / early bladder cancer / MS / noninvasive disease / common cancer / cancer / both noninvasive disease / disease / flushing / unresectable/metastatic disease / tumour / female cancers / female cancer / BACKGROUND Bladder cancer / search term bladder cancer / male cancer / /
U.S. Department of Health and Human Services / American Joint Committee on Cancer / BCG Administration / Canadian Urology Association / European Association of Urology / American Urological Association / Alberta Genitourinary Tumour Team / Guideline Utilization Resource Unit / /
Clinical Practice Guideline